165 related articles for article (PubMed ID: 29701071)
1. Surface plasmon resonance as a tool for ligand-binding assay reagent characterization in bioanalysis of biotherapeutics.
Duo J; Bruno J; Kozhich A; David-Brown D; Luo L; Kwok S; Santockyte R; Haulenbeek J; Liu R; Hamuro L; Peterson JE; Piccoli S; DeSilva B; Pillutla R; Zhang YJ
Bioanalysis; 2018 Apr; 10(8):559-576. PubMed ID: 29701071
[TBL] [Abstract][Full Text] [Related]
2. Critical reagents for ligand-binding assays: process development methodologies to enable high-quality reagents.
Kittinger C; Delmar J; Hewitt L; Holcomb R; Jones C; Jones H; Kubiak R; Lee N; McClenny LC; Mody N; O'Connor E
Bioanalysis; 2022 Feb; 14(3):117-135. PubMed ID: 35019733
[TBL] [Abstract][Full Text] [Related]
3. Characterization of labeled reagents in ligand-binding assays by a surface plasmon resonance biosensor.
Duo J; Bruno J; Piccoli S; DeSilva B; Zhang YJ
Bioanalysis; 2017 Jan; 9(2):193-207. PubMed ID: 27960543
[TBL] [Abstract][Full Text] [Related]
4. The impact of ligand binding based assays critical reagent characterization and storage.
Haulenbeek J; Beaver CJ
Bioanalysis; 2021 May; 13(10):797-805. PubMed ID: 34002637
[TBL] [Abstract][Full Text] [Related]
5. Recent advances in surface plasmon resonance based techniques for bioanalysis.
Phillips KS; Cheng Q
Anal Bioanal Chem; 2007 Mar; 387(5):1831-40. PubMed ID: 17203259
[TBL] [Abstract][Full Text] [Related]
6. Critical reagent generation, characterization, handling and storage workflows: impact on ligand binding assays.
Oquendo E; Savoie J; Swenson JM; Grimaldi C
Bioanalysis; 2021 May; 13(10):847-860. PubMed ID: 33890503
[TBL] [Abstract][Full Text] [Related]
7. 2022 White Paper on Recent Issues in Bioanalysis: Enzyme Assay Validation, BAV for Primary End Points, Vaccine Functional Assays, Cytometry in Tissue, LBA in Rare Matrices, Complex NAb Assays, Spectral Cytometry, Endogenous Analytes, Extracellular Vesicles
Sumner G; Keller S; Huleatt J; Staack RF; Wagner L; Azadeh M; Bandukwala A; Cao L; Du X; Salinas GF; Garofolo F; Harris S; Hopper S; Irwin C; Ji Q; Joseph J; King L; Kinhikar A; Lu Y; Luo R; Mabrouk O; Malvaux L; Marshall JC; McGuire K; Mikol V; Neely R; Qiu X; Saito Y; Salaun B; Scully I; Smeraglia J; Solstad T; Stoop J; Tang H; Teixeira P; Wang Y; Wright M; Mendez L; Beaver C; Eacret J; Au-Yeung A; Decman V; Dessy F; Eck S; Goihberg P; Alcaide EG; Gonneau C; Grugan K; Hedrick MN; Kar S; Sehra S; Stevens E; Stevens C; Sun Y; McCush F; Williams L; Fischer S; Wu B; Jordan G; Burns C; Cludts I; Coble K; Grimaldi C; Henderson N; Joyce A; Lotz G; Lu Y; Luo L; Neff F; Sperinde G; Stubenrauch KG; Wang Y; Ware M; Xu W
Bioanalysis; 2023 Aug; 15(15):861-903. PubMed ID: 37584363
[TBL] [Abstract][Full Text] [Related]
8. SPR-based assays enable the full functional analysis of bispecific molecules.
Meschendoerfer W; Gassner C; Lipsmeier F; Regula JT; Moelleken J
J Pharm Biomed Anal; 2017 Jan; 132():141-147. PubMed ID: 27721070
[TBL] [Abstract][Full Text] [Related]
9. Development of surface plasmon resonance biosensor assays for primary and secondary screening of acetylcholine binding protein ligands.
Retra K; Geitmann M; Kool J; Smit AB; de Esch IJ; Danielson UH; Irth H
Anal Biochem; 2010 Dec; 407(1):58-64. PubMed ID: 20599657
[TBL] [Abstract][Full Text] [Related]
10. Accelerating Regulated Bioanalysis for Biotherapeutics: Case Examples Using a Microfluidic Ligand Binding Assay Platform.
Liu R; Hoffpauir B; Chilewski SD; Gamberdella J; Kavita U; Duo J; Gleason C; Zhang Y; Pillutla R; DeSilva B; Hamuro L
AAPS J; 2017 Jan; 19(1):82-91. PubMed ID: 27796911
[TBL] [Abstract][Full Text] [Related]
11. Surface plasmon resonance spectroscopy for characterisation of membrane protein-ligand interactions and its potential for drug discovery.
Patching SG
Biochim Biophys Acta; 2014 Jan; 1838(1 Pt A):43-55. PubMed ID: 23665295
[TBL] [Abstract][Full Text] [Related]
12. Adventures in critical reagent lot changes in ligand-binding assays: redevelopment, bridging and additional processing requirements.
Rauwerdink A; Benson M; Jayne A; Babu S; St Charles J; Smith A
Bioanalysis; 2021 May; 13(10):771-777. PubMed ID: 33884890
[No Abstract] [Full Text] [Related]
13. Life cycle management of critical ligand-binding reagents.
O'Hara DM; Theobald V
Bioanalysis; 2013 Nov; 5(21):2679-96. PubMed ID: 24180507
[TBL] [Abstract][Full Text] [Related]
14. Applications of Surface Plasmon Resonance and Biolayer Interferometry for Virus-Ligand Binding.
Murali S; Rustandi RR; Zheng X; Payne A; Shang L
Viruses; 2022 Mar; 14(4):. PubMed ID: 35458446
[TBL] [Abstract][Full Text] [Related]
15. Critical reagent characterization and re-evaluation to ensure long-term stability: two case studies.
Caiazzo TM; Shea CM; Joyce AP
Bioanalysis; 2021 May; 13(10):807-815. PubMed ID: 33884894
[TBL] [Abstract][Full Text] [Related]
16. 2023 White Paper on Recent Issues in Bioanalysis: EU IVDR 2017/746 Implementation/Impact, IVD/CDx/CLIA Approved Assays, High Dimensional Cytometry, Multiplexing Technologies, LBA Tissue Analysis, Vaccine Study Endpoints, Cell-Based Assays for Biomarkers, Cell Therapy and Vaccines (
Kholmanskikh O; Wang YM; Hersey S; Wadhwa M; Block K; Bandukwala A; Szapacs M; Weiner R; Awwad K; Dessy F; Downing S; Du X; Garofolo F; Harris S; Hou V; Jones J; Kar S; Kinhikar A; Li M; Mathews J; Meissen J; Sumner GO; Pan L; Sanderink G; Scully I; Stanta J; Tanaka Y; Vauleon S; Wagner L; Wang K; Zhu L; Eck S; Lin YD; Azadeh M; Decman V; Diebold S; Du X; Goihberg P; Alcaide EG; Gonneau C; Hedrick MN; Hopkins G; Kar S; Loschko J; McCausland M; Mendez L; Sehra S; Stevens E; Sun YS; Tangri S; Trampont PC; Cludts I; Dysinger M; Kavita U; Sugimoto H; Chilewski S; Grimaldi C; Jiang Y; Kamerud J; Liu S; Owen C; Palackal N; Petit-Frere C; Pine S; Abhari MR; Scheibner K; Williams L; Xu T; Zhang G
Bioanalysis; 2024; 16(8):179-220. PubMed ID: 38899739
[TBL] [Abstract][Full Text] [Related]
17. Current Trends in Ligand Binding Real-Time Measurement Technologies.
Fraser S; Shih JY; Ware M; O'Connor E; Cameron MJ; Schwickart M; Zhao X; Regnstrom K
AAPS J; 2017 May; 19(3):682-691. PubMed ID: 28321830
[TBL] [Abstract][Full Text] [Related]
18. Surface plasmon resonance biosensing.
Piliarik M; Vaisocherová H; Homola J
Methods Mol Biol; 2009; 503():65-88. PubMed ID: 19151937
[TBL] [Abstract][Full Text] [Related]
19. Label-free technologies and pharmacology.
Fang Y
Pharmacol Res; 2016 Jun; 108():88-89. PubMed ID: 27155057
[No Abstract] [Full Text] [Related]
20. Current and effective strategies for critical reagent characterization, storage, stability, retesting and life cycle management for ligand-binding assays and flow cytometry.
Amaravadi L; Palackal N; Garofolo F
Bioanalysis; 2021 May; 13(10):737-740. PubMed ID: 34037426
[No Abstract] [Full Text] [Related]
[Next] [New Search]